Icon PLC (NASDAQ:ICLR) shares saw unusually-high trading volume on Thursday . Approximately 1,090,263 shares traded hands during mid-day trading, an increase of 73% from the previous session’s volume of 629,991 shares.The stock last traded at $70.81 and had previously closed at $71.10.

ICLR has been the topic of a number of analyst reports. Zacks Investment Research cut shares of Icon PLC from a “buy” rating to a “hold” rating in a report on Wednesday, April 27th. Jefferies Group cut shares of Icon PLC from a “buy” rating to a “hold” rating and lowered their target price for the company from $80.00 to $78.00 in a research note on Friday, June 3rd. Robert W. Baird reissued an “outperform” rating and set a $83.00 target price on shares of Icon PLC in a research note on Monday, June 27th. Credit Suisse Group AG started coverage on shares of Icon PLC in a research note on Monday, June 20th. They set an “outperform” rating and a $80.00 target price on the stock. Finally, Avondale Partners cut shares of Icon PLC from a “market perform” rating to an “underperform” rating and lowered their target price for the company from $70.00 to $59.00 in a research note on Wednesday, June 8th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and four have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $77.43.

The firm has a market cap of $4.01 billion and a P/E ratio of 17.37. The stock has a 50-day moving average of $68.14 and a 200 day moving average of $69.78.

Icon PLC (NASDAQ:ICLR) last posted its quarterly earnings results on Tuesday, April 26th. The company reported $1.12 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.11 by $0.01. The business had revenue of $400.50 million for the quarter, compared to analyst estimates of $414.35 million. The firm’s quarterly revenue was up 3.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.86 EPS. Equities analysts expect that Icon PLC will post $4.71 earnings per share for the current fiscal year.

Several large investors have recently modified their holdings of ICLR. Globeflex Capital L P increased its stake in shares of Icon PLC by 10.4% in the fourth quarter. Globeflex Capital L P now owns 268,600 shares of the company’s stock valued at $20,870,000 after buying an additional 25,200 shares in the last quarter. American Capital Management Inc. increased its stake in shares of Icon PLC by 2.5% in the fourth quarter. American Capital Management Inc. now owns 777,635 shares of the company’s stock valued at $60,422,000 after buying an additional 18,930 shares in the last quarter. Strategic Global Advisors LLC increased its stake in shares of Icon PLC by 23.1% in the fourth quarter. Strategic Global Advisors LLC now owns 27,689 shares of the company’s stock valued at $2,151,000 after buying an additional 5,200 shares in the last quarter. Deere & Co. increased its stake in shares of Icon PLC by 11.6% in the fourth quarter. Deere & Co. now owns 23,047 shares of the company’s stock valued at $1,791,000 after buying an additional 2,398 shares in the last quarter. Finally, WCM Investment Management CA increased its stake in shares of Icon PLC by 7.1% in the fourth quarter. WCM Investment Management CA now owns 4,490,038 shares of the company’s stock valued at $348,876,000 after buying an additional 297,587 shares in the last quarter.

ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.